Financhill
Back

Pliant Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing selling pressure, which indicates risk of future bearish movement.

Pliant Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 13.75 Sell
20-day SMA: 14.01 Sell
50-day SMA: 14.02 Sell
200-day SMA: 13.15 Buy
8-day EMA: 13.74 Sell
20-day EMA: 13.88 Sell
50-day EMA: 13.7 Sell
200-day EMA: 13.81 Sell

Pliant Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 43.96 Sell
Chaikin Money Flow: -1153411 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.93 - 14.55) Sell
Bollinger Bands (100): (12.02 - 14.42) Buy

Pliant Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Pliant Therapeutics Stock

Is Pliant Therapeutics Stock a Buy?

PLRX Technical Analysis vs Fundamental Analysis

Sell
29
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?

Pliant Therapeutics Stock Info

Market Cap:
804.5M
Price in USD:
13.22
Share Volume:
1.9M

Pliant Therapeutics 52-Week Range

52-Week High:
19.62
52-Week Low:
10.22
Sell
29
Pliant Therapeutics (PLRX) is a Sell

Pliant Therapeutics Share Price Forecast

Is Pliant Therapeutics Stock a Buy?

  • Pliant Therapeutics share price is 13.22 while PLRX 8-day exponential moving average is 13.74, which is a Sell signal.
  • The stock price of PLRX is 13.22 while Pliant Therapeutics 20-day EMA is 13.88, which makes it a Sell.
  • Pliant Therapeutics 50-day exponential moving average is 13.70 while PLRX share price is 13.22, making it a Sell technically.
  • PLRX stock price is 13.22 and Pliant Therapeutics 200-day simple moving average is 13.81, creating a Sell signal.

Fundamental Analysis of Pliant Therapeutics

Is Pliant Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.33 per share.

Technical Analysis of Pliant Therapeutics

Should I short Pliant Therapeutics stock?

* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.